So! Bring us some facts, not just your usual drivel, and maybe someone will respond. First you need to establish some credibility.
Aurus seems to be on the right road by sending their representative to Delaware. We shall see. They have the funding and are definitely establishing credibility. Will they be able to provide Russian documents that meet US requirements for establishing an OTC account? Don't ask me. Do some DD, instead of accentuating the negative and complaining about no progress.